In the last trading session, 2.76 million shares of the ATAI Life Sciences N.V (NASDAQ:ATAI) were traded, and its beta was 1.19. Most recently the company’s share price was $1.50, and it changed around -$0.22 or -12.79% from the last close, which brings the market valuation of the company to $290.99M. ATAI currently trades at a discount to its 52-week high of $2.85, offering almost -90.0% off that amount. The share price’s 52-week low was $1.03, which indicates that the current value has risen by an impressive 31.33% since then.
ATAI Life Sciences N.V stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended ATAI as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. ATAI Life Sciences N.V is expected to report earnings per share of -0.15 for the current quarter.
ATAI Life Sciences N.V (NASDAQ:ATAI) trade information
Instantly ATAI has showed a red trend with a performance of -12.79% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.8700 on recent trading dayincreased the stock’s daily price by 19.79%. The company’s shares are currently up 12.78% year-to-date, but still down -17.58% over the last five days. On the other hand, ATAI Life Sciences N.V (NASDAQ:ATAI) is -6.25% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 75.0% from its current value. Analyst projections state that ATAI is forecast to be at a low of $6 and a high of $6.
ATAI Life Sciences N.V (ATAI) estimates and forecasts
The year-over-year growth rate is expected to be 159.03%, up from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 250k in revenue for the current quarter. Analysts predict that the company’s current quarter sales will jump, forecast at 1,288.89%. Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 44.19%.
ATAI Dividends
ATAI Life Sciences N.V’s next quarterly earnings report is expected to be released in April.
MORGAN STANLEY, with 1.7111% or 2.72 million shares worth $3.62 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Morgan Stanley Inst Fund Inc-Inception Port and Vanguard Health Care Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 511.99 shares worth $0.77 million, making up 0.31% of all outstanding shares. On the other hand, Vanguard Health Care Index Fund held roughly 404.81 shares worth around $0.61 million, which represents about 0.24% of the total shares outstanding.
